Have a personal or library account? Click to login
Assessment of the Nicotine Pharmacokinetics When Using Two Types of E-Cigarettes in Healthy Adults Who Smoke: Results From Two Randomized, Crossover Studies Cover

Assessment of the Nicotine Pharmacokinetics When Using Two Types of E-Cigarettes in Healthy Adults Who Smoke: Results From Two Randomized, Crossover Studies

Open Access
|Aug 2024

References

  1. U.S. Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC), National Center for Chronic Desease Prevention and Health Promotion, and Office on Smoking and Health: The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General; DHHS, Atlanta, GA, USA, 2014, 943 p. Available at: https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf (accessed June 2024)
  2. Institute of Medicine (IOM): Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; edited by K. Stratton, P. Shetty, et al., National Academies Press, Washington, DC, USA, 2001, 656 p., ISBN: 978-0-309-07282-3.
  3. Dinakar, C. and G.T. O’Connor: The Health Effects of Electronic Cigarettes; N. Engl. J. Med. 375 (2016) 1372–1381. DOI: 10.1056/NEJMra1502466
  4. McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products 2018: A Report Commissioned by Public Health England. 2018; Public Health England, London, UK, 2018, pp. 1–243.
  5. Goniewicz, M.L., C.R. Miller, E. Sutanto, and D. Li: How Effective Are Electronic Cigarettes for Reducing Respiratory and Cardiovascular Risk in Smokers? A Systematic Review; Harm Reduct. J. 17 (2020) 91. DOI: 10.1186/s12954-020-00440-w
  6. Akiyama, Y. and N. Sherwood: Systematic Review of Biomarker Findings from Clinical Studies of Electronic Cigarettes and Heated Tobacco Products; Toxicol. Rep. 8 (2021) 282–294. DOI: 10.1016/j.toxrep.2021.01.014
  7. Kanobe, M.N., P.R. Nelson, B.G. Brown, P. Chen, P. Makena, J.W. Caraway, G.L. Prasad, and E.K. Round: Changes in Biomarkers of Exposure and Potential Harm in Smokers Switched to Vuse Vibe or Vuse Ciro Electronic Nicotine Delivery Systems; Toxics 11 (2023) 564. DOI: 10.3390/toxics11070564
  8. Fearon, I.M., A.C. Eldridge, N. Gale, M. McEwan, M.F. Stiles, and E.K. Round: Nicotine Pharmacokinetics of Electronic Cigarettes: A Review of the Literature; Regul. Toxicol. Pharmacol. 100 (2018) 25–34. DOI: 10.1016/j.yrtph.2018.09.004
  9. DeVito, E.E. and S. Krishnan-Sarin: E-Cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure; Curr. Neuropharmacol. 16 (2018) 438–459. DOI: 10.2174/1570159X15666171016164430
  10. Voos, N., M.L. Goniewicz, and T. Eissenberg: What Is the Nicotine Delivery Profile of Electronic Cigarettes?; Expert Opin. Drug Deliv. 16 (2019) 1193–1203. DOI: 10.1080/17425247.2019.1665647
  11. Jacobson, K., J. Martinez, S. Larroque, I.W. Jones, and T. Paschke: Nicotine Pharmacokinetics of Electronic Cigarettes: A Pooled Data Analysis from the Literature; Toxicol. Rep. 8 (2020) 84–95. DOI: 10.1016/j.toxrep.2020.12.016
  12. Fearon, I.M., K. Gilligan, R.G.N. Seltzer, and W. McKinney: A Randomised, Crossover, Clinical Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the Bidi® Stick ENDS Compared with Combustible Cigarettes and a Comparator ENDS in Adult Smokers; Harm Reduct. J. 19 (2022) 57. DOI: 10.1186/s12954-022-00638-0
  13. Goniewicz, M.L., T. Kuma, M. Gawron, J. Knysak, and L. Kosmider: Nicotine Levels in Electronic Cigarettes; Nicotine Tob. Res. 15 (2013) 158–166. DOI: 10.1093/ntr/nts103
  14. Farsalinos, K.E., G. Romagna, D. Tsiapras, S. Kyrzopoulos, and V. Voudris: Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ Regulation; Int. J. Environ. Res. Public Health 10 (2013) 2500–2514. DOI: 10.3390/ijerph10062500
  15. Hajek, P., M.L. Goniewicz, A. Phillips, K. Myers Smith, O. West, and H. McRobbie: Nicotine Intake from Electronic Cigarettes on Initial Use and after 4 Weeks of Regular Use; Nicotine Tob. Res. 17 (2015) 175–179. DOI: 10.1093/ntr/ntu153
  16. St Helen, G., D.A. Dempsey, C.M. Havel, P. Jacob III, and N.L. Benowitz: Impact of E-Liquid Flavors on Nicotine Intake and Pharmacology of E-Cigarettes; Drug Alcohol Depend. 178 (2017) 391–398. DOI: 10.1016/j.drugalcdep.2017.05.042
  17. St Helen, G., M. Shahid, S. Chu, and N.L. Benowitz: Impact of E-Liquid Flavors on E-Cigarette Vaping Behavior; Drug Alcohol Depend. 189 (2018) 42–48. DOI: 10.1016/j.drugalcdep.2018.04.032
  18. Voos, N., D. Smith, L. Kaiser, M.C. Mahoney, C.M. Bradizza, L.T. Kozlowski, N.L. Benowitz, R.J. O’Connor, and M.L. Goniewicz: Effect of E-Cigarette Flavors on Nicotine Delivery and Puffing Topography: Results from a Randomized Clinical Trial of Daily Smokers; Psychopharmacology 237 (2020) 491–502. DOI: 10.1007/s00213-019-05386-x
  19. Keyser, B.M., K.S. Hong, P. DeLuca, T. Jin, B.A. Jones, P. Nelson, E. Schmidt, and E.K. Round: Part Two: An Unblinded, Parallel, Randomized Study to Assess Nicotine Pharmacokinetics of Four Vuse Solo ENDS Flavors in Smokers; Sci. Rep. 13 (2023) 8894. DOI: 10.1038/s41598-023-35439-3
  20. Prasad, K., A. Gray, and L. Edward: Actual Use Puffing Topography and Mouth Level Exposure to Aerosol and Nicotine for an Evolving Series of Electronic Nicotine Delivery Systems; Int. J. Sci. Rep. 8 (2022) 366–376. DOI: 10.18203/issn.2454-2156.IntJSciRep20223033
  21. McAdam, K., P. Davis, L. Ashmore, D. Eaton, B. Jakaj, A. Eldridge, and C. Liu: Influence of Machine-Based Puffing Parameters on Aerosol and Smoke Emissions from Next Generation Nicotine Inhalation Products; Reg. Toxicol. Pharmacol. 101 (2019) 156–165. DOI: 10.1016/j.yrtph.2018.11.006
  22. Visser, W.F., E.J.Z. Krüsemann, W.N.M. Klerx, K. Boer, N. Weibolt, and R. Talhout: Improving the Analysis of E-Cigarette Emissions: Detecting Human “Dry Puff” Conditions in a Laboratory as Validated by a Panel of Experienced Vapers; Int. J. Environ. Res. Public Health 18 (2021) 11520. DOI: 10.3390/ijerph182111520
  23. Gupta, A., R. Tayyarah, G. Gillman, C. Garner, and R. Stevens: Machine Vaping of Electronic Cigarettes - A Comparison of Puffing Regimes; Contrib. Tob. Nicotine Res. 30 (2021) 127–136. DOI: 10.2478/cttr-2021-0009
  24. Dawkins, L., C. Kimber, M. Doig, C. Feyerabend, and O. Corcoran: Self-Titration by Experienced E-Cigarette Users: Blood Nicotine Delivery and Subjective Effects; Psychopharmacology 233 (2016) 2933–2941. DOI: 10.1007/s00213-016-4338-2
  25. Hiler, M., A. Breland, T. Spindle, S. Maloney, T. Lipato, N. Karaoghlanian, A. Shihadeh, A. Lopez, C. Ramoa, and T. Eissenberg: Electronic Cigarette User Plasma Nicotine Concentration, Puff Topography, Heart Rate, and Subjective Effects: Influence of Liquid Nicotine Concentration and User Experience; Exp. Clin. Psychopharmacol. 25 (2017) 380–392. DOI: 10.1037/pha0000140
  26. Blank, M.D., J. Pearson, C.O. Cobb, N.J. Felicione, M.M. Hiler, T.R. Spindle, and A. Breland: What Factors Reliably Predict Electronic Cigarette Nicotine Delivery?; Tob. Control 29 (2020) 644–651. DOI: 10.1136/tobaccocontrol-2019-055193
  27. Garg, M., R. Naidu, K. Iyer, and R. Jadhav: Bioequivalence of Two Different Nicotine Chewing Gum Formulations of Two Different Strengths (2 mg and 4 mg) in Indian Healthy Adult Human Male Smoker Subjects; J. Bioequiv. Availab. 08 (2016) 74–79. DOI: 10.4172/jbb.1000271
  28. Heatherton, T.F., L.T. Kozlowski, R.C. Frecker, and K.-O. Fagerström: The Fagerström Test for Nicotine Dependence: a Revision of the Fagerström Tolerance Questionnaire; Br. J. Addict. 86 (1991) 1119–1127. DOI: 10.1111/j.1360-0443.1991.tb01879.x
  29. Fagerström, K.: Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence; Nicotine Tob. Res. 14 (2012) 75–78. DOI: 10.1093/ntr/ntr137
  30. Miller, E.I., H.-R.K. Norris, D.E. Rollins, S.T. Tiffany, and D.G. Wilkins: A Novel Validated Procedure for the Determination of Nicotine, Eight Nicotine Metabolites and Two Minor Tobacco Alkaloids in Human Plasma or Urine by Solid-Phase Extraction Coupled with Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry; J. Chromatogr. B 878 (2010) 725–737. DOI: 10.1016/j.jchromb.2009.12.018
  31. Cappelleri, J.C., A.G. Bushmakin, C.L. Baker, E. Merikle, A.O. Olufade, and D.G. Gilbert: Confirmatory Factor Analyses and Reliability of the Modified Cigarette Evaluation Questionnaire; Addict. Behav. 32 (2007) 912–923. DOI: 10.1016/j.addbeh.2006.06.028
  32. Farsalinos, K., K. Poulas, and V. Voudris: Changes in Puffing Topography and Nicotine Consumption Depending on the Power Setting of Electronic Cigarettes; Nicotine Tob. Res. 20 (2018) 993–997. DOI: 10.1093/ntr/ntx219
  33. Liu, J., J. Rensch, J. Wang, X. Jin, A. Vansickel, J. Edmiston, and M. Sarkar: Nicotine Pharmacokinetics and Subjective Responses after Using Nicotine Pouches with Different Nicotine Levels Compared to Combustible Cigarettes and Moist Smokeless Tobacco in Adult Tobacco Users; Psychopharmacology 239 (2022) 2863–2873. DOI: 10.1007/s00213-022-06172-y
  34. Patterson, F., N. Benowitz, P. Shields, V. Kaufmann, C. Jepson, P. Wileyto, S. Kucharski, and C. Lerman: Individual Differences in Nicotine Intake Per Cigarette; Cancer Epidemiol. Biomarkers Prev. 12 (2003) 468–471.
  35. Walele, T., G. Sharma, R. Savioz, C. Martin, and J. Williams: A Randomised, Crossover Study on an Electronic Vapour Product, a Nicotine Inhalator and a Conventional Cigarette. Part A: Pharmacokinetics; Regul. Toxicol. Pharmacol. 74 (2016) 187–192. DOI: 10.1016/j.yrtph.2015.12.003
  36. Stiles, M.F., L.R. Campbell, D.W. Graff, B.A. Jones, R.V. Fant, and J.E. Henningfield: Pharmacodynamic and Pharmacokinetic Assessment of Electronic Cigarettes, Combustible Cigarettes, and Nicotine Gum: Implications for Abuse Liability; Psychopharmacology 234 (2017) 2643–2655. DOI: 10.1007/s00213-017-4665-y
  37. Stiles, M.F., L.R. Campbell, T. Jin, D.W. Graff, R.V. Fant, and J.E. Henningfield: Assessment of the Abuse Liability of Three Menthol Vuse Solo Electronic Cigarettes Relative to Combustible Cigarettes and Nicotine Gum; Psychopharmacology 235 (2018) 2077–2086. DOI: 10.1007/s00213-018-4904-x
  38. O’Connell, G., J.D. Pritchard, C. Prue, J. Thompson, T. Verron, D. Graff, and T. Walele: A Randomised, Open-Label, Cross-over Clinical Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes with Nicotine Salt Formulations in U.S. Adult Smokers; Intern. Emerg. Med. 14 (2019) 853–861. DOI: 10.1007/s11739-019-02025-3
  39. Ebajemito, J.K., M. McEwan, N. Gale, O.M. Camacho, G. Hardie, and C.J. Proctor: A Randomised Controlled Single-Centre Open-Label Pharmacokinetic Study to Examine Various Approaches of Nicotine Delivery Using Electronic Cigarettes; Sci. Rep. 10 (2020) 19980. DOI: 10.1038/s41598-020-76610-4
  40. Behar, R.Z., M. Hua, and P. Talbot: Puffing Topography and Nicotine Intake of Electronic Cigarette Users; PLoS One 10 (2015) e0117222. DOI: 10.1371/journal.pone.0117222
  41. Vansickel, A.R., J.S. Edmiston, Q.W. Liang, C. Duhon, C. Connell, D. Bennett, and M. Sarkar: Characterization of Puff Topography of a Prototype Electronic Cigarette in Adult Exclusive Cigarette Smokers and Adult Exclusive Electronic Cigarette Users; Regul. Toxicol. Pharmacol. 98 (2018) 250–256. DOI: 10.1016/j.yrtph.2018.07.019
  42. Gao, X., M. Fewx, J. Sprock, H. Jiang, Y. Gao, and Y. Liu: A Novel Puff Recording Electronic Nicotine Delivery System for Assessing Naturalistic Puff Topography and Nicotine Consumption During Ad Libitum Use: Ancillary Study; JMIR Form. Res. 7 (2023) e42544. DOI: 10.2196/42544
  43. Goldenson, N.I., I.M. Fearon, A.R. Buchhalter, and J.E. Henningfield: An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers; Nicotine Tob. Res. 23 (2021) 947–955. DOI: 10.1093/ntr/ntab001
  44. Mallock, N., A. Rabenstein, S. Gernun, P. Laux, C. Hutzler, S. Karch, G. Koller, F. Henkler-Stephani, M.K. Parr, O. Pogarell, A. Luch, and T. Rüther: Nicotine Delivery and Relief of Craving after Consumption of European JUUL E-Cigarettes prior and after Pod Modification; Sci. Rep. 11 (2021) 12078. DOI: 10.1038/s41598-021-91593-6
  45. St.Helen, G., N. Nardone, N. Addo, D. Dempsey, C. Havel, P. Jacob III, and N.L. Benowitz: Differences in Nicotine Intake and Effects from Electronic and Combustible Cigarettes among Dual Users; Addiction 115 (2020) 757–767. DOI: 10.1111/add.14884
  46. Campbell, C., T. Jin, E.K. Round, E. Schmidt, P. Nelson, and S. Baxter: Part One: Abuse Liability of Vuse Solo (G2) Electronic Nicotine Delivery System Relative to Combustible Cigarettes and Nicotine Gum; Sci. Rep. 12 (2022) 22080. DOI: 10.1038/s41598-022-26417-2
  47. Hanson, K., R. O’Connor, and D. Hatsukami: Measures for Assessing Subjective Effects of Potential Reduced-Exposure Products; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3209–3224. DOI: 10.1158/1055-9965.EPI-09-0971
  48. Carter, L.P., M.L. Stitzer, J.E. Henningfield, R.J. O’Connor, K.M. Cummings, and D.K. Hatsukami: Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3241–3262. DOI: 10.1158/1055-9965.EPI-09-0948
  49. U.S. Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Tobacco Products (CTP): Guidance for Industry - Modified Risk Tobacco Product Applications - Draft Guidance; DHHS, Rockville, MD, USA, 2012. Available at: https://www.fda.gov/media/83300/download (accessed June 2024)
  50. Vansickel, A., S. Baxter, N. Sherwood, M. Kong, and L. Campbell: Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations; Nicotine Tob. Res. 24 (2022) 295–305. DOI: 10.1093/ntr/ntab183
  51. Hukkanen, J., P. Jacob III, and N.L. Benowitz: Metabolism and Disposition Kinetics of Nicotine; Pharmacol. Rev. 57 (2005) 79–115. DOI: 10.1124/pr.57.1.3
  52. St.Helen, G., C. Havel, D.A. Dempsey, P. Jacob III, and N.L. Benowitz: Nicotine Delivery, Retention and Pharmacokinetics from Various Electronic Cigarettes; Addiction 111 (2016) 535–544. DOI: 10.1111/add.13183
  53. Pagano, T., A.G. DiFrancesco, S.B. Smith, J. George, G. Wink, I. Rahman, and R.J. Robinson: Determination of Nicotine Content and Delivery in Disposable Electronic Cigarettes Available in the United States by Gas Chromatography-Mass Spectrometry; Nicotine Tob. Res. 18 (2016) 700–707. DOI: 10.1093/ntr/ntv120
  54. Omaiye, E.E., K.J. McWhirter, W. Luo, J.F. Pankow, and P. Talbot: High-Nicotine Electronic Cigarette Products: Toxicity of JUUL Fluids and Aerosols Correlates Strongly with Nicotine and Some Flavor Chemical Concentrations; Chem. Res. in Toxicol. 32 (2019) 1058–1069. DOI: 10.1021/acs.chemrestox.8b00381
Language: English
Page range: 173 - 188
Submitted on: Jan 28, 2024
Accepted on: Apr 24, 2024
Published on: Aug 21, 2024
Published by: Institut für Tabakforschung GmbH
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Dai Yuki, Lesley Giles, Sylvain Larroque, Sam Harbo, Anthony Hemsley, Javier Martinez, published by Institut für Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.